From the Mood Disorders Unity-ProGruda and Service of Interdisciplinary Neuromodulation; Department and Institute of Psychiatry, Faculty of Medicine (Carneiro), University of São Paulo, São Paulo, Brazil; Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital (Pacheco-Barrios, Andrade, Martinez-Magallanes, Pichardo, Fregni), Harvard Medical School, Boston, Massachusetts; Universidad San Ignacio de Loyola, Vicerrectorado de Investigación, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud (Pacheco-Barrios), Lima, Peru; Post-Graduate Program in Medical Sciences, School of Medicine (Caumo), Universidade Federal do Rio Grande do Sul; and Laboratory of Pain and Neuromodulation at Hospital de Clínicas de Porto Alegre (Caumo), Porto Alegre, Rio Grande do Sul, Brazil.
Psychosom Med. 2024;86(9):781-789. doi: 10.1097/PSY.0000000000001343. Epub 2024 Aug 28.
Considering the growing evidence that psychological variables might contribute to fibromyalgia syndrome (FMS), our study aims to understand the impact of psychological factors in quantitative sensory testing (QST) in FMS patients by performing a systematic review with meta-analysis.
A systematic search was carried out in PubMed/MEDLINE, EMBASE, Web of Science, and PsycINFO databases for records up until January 2024. We included 20 studies ( n = 1623, 16 randomized controlled trials, and 4 nonrandomized controlled trials) with low or moderate risk of bias included.
From nonrandomized evidence, our meta-analysis found a baseline relationship between anxiety, depression, and pain catastrophizing and QST measures in FMS patients. Higher pain catastrophizing levels were associated with less efficient conditioned pain modulation. Higher anxiety and depression were associated with lower pain threshold (PT). Randomized evidence showed a statistically significant increase in PT after fibromyalgia treatments (effect size = 0.29, 95% confidence interval = 0.03-0.56). The effect was not influenced by treatment type. Moreover, we found that only anxiety levels before treatment negatively influenced the PT improvements after treatment.
FMS patients with higher anxiety levels at baseline showed a smaller increase in PT after the intervention. Depression factor was not significant in either changes in anxiety or depression. Baseline anxiety levels should be monitored as possible confounders of QST measurements. Understanding how psychological factors and QST are related in FMS patients is critical for improving the syndrome's management and treatment.Protocol Registration: CRD42023429397.
鉴于越来越多的证据表明心理变量可能与纤维肌痛综合征(FMS)有关,我们的研究旨在通过系统评价和荟萃分析了解心理因素对 FMS 患者定量感觉测试(QST)的影响。
在 PubMed/MEDLINE、EMBASE、Web of Science 和 PsycINFO 数据库中进行了系统检索,检索时间截至 2024 年 1 月。我们纳入了 20 项研究(n=1623,16 项随机对照试验和 4 项非随机对照试验),这些研究的偏倚风险较低或为中度。
从非随机证据来看,我们的荟萃分析发现 FMS 患者的焦虑、抑郁和疼痛灾难化与 QST 测量之间存在基线关系。较高的疼痛灾难化水平与更有效的条件性疼痛调制降低有关。较高的焦虑和抑郁水平与较低的疼痛阈值(PT)有关。随机证据显示,在接受纤维肌痛治疗后,PT 有统计学上显著的增加(效应量=0.29,95%置信区间=0.03-0.56)。治疗类型对效果没有影响。此外,我们发现,只有治疗前的焦虑水平会对治疗后 PT 的改善产生负面影响。
基线时焦虑水平较高的 FMS 患者在干预后 PT 的增加较小。在焦虑或抑郁的变化中,抑郁因素并不显著。治疗前的焦虑水平应作为 QST 测量的可能混杂因素进行监测。了解心理因素和 QST 在 FMS 患者中的关系对于改善该综合征的管理和治疗至关重要。
CRD42023429397。